Does the Intersectionality of Race/Ethnicity and Type 2 Diabetes Increase the Odds of a Cervical Cancer Diagnosis? A Nested Case–Control Study of a Florida Statewide Multisite EHR Database

Cervical cancer and Type 2 Diabetes (T2D) share common demographic risk factors. Despite this, scarce research has examined the relationship between race/ethnicity, having T2D, and cervical cancer incidence. We analyzed statewide electronic health records data between 2012 and 2019 from the OneFlorida+ Data Trust. We created a 1:4 nested case–control dataset. Each case (patient with cervical cancer) was matched with four controls (patients without cervical cancer) without replacement by year of encounter, diagnosis, and age. We used conditional logistic regression to estimate the unadjusted and adjusted odds ratios (ORs) and 95% confidence intervals (CIs) to examine the association between race/ethnicity, T2D, and cervical cancer incidence. A total of 100,739 cases and 402,956 matched controls were identified. After adjusting for sociodemographic characteristics, non-Hispanic Black women with T2D had higher odds of cervical cancer compared with non-Hispanic White women with T2D (OR: 1.58, 95% CI 1.41–1.77). Living in a rural area, having Medicaid/Medicare insurance, and having high social vulnerability were associated with higher odds of having a cervical cancer diagnosis. Our findings imply the need to address the higher burden of cervical cancer diagnosis among non-Hispanic Black women with T2D and in underserved populations.

[1]  D. Kapp,et al.  The increasing incidence of stage IV cervical cancer in the USA: what factors are related? , 2022, International Journal of Gynecological Cancer.

[2]  Eric A. Miller,et al.  Cervical cancer screening and predictors of screening by diabetes status , 2022, Cancer Causes & Control.

[3]  L. Thorpe,et al.  1262-P: Developing a Computable Phenotype Algorithm for Identification of Children and Adolescents with Diabetes Using Electronic Health Records , 2022, Diabetes.

[4]  E. Shenkman,et al.  Clinicians’ perceptions of barriers to cervical cancer screening for women living with behavioral health conditions: a focus group study , 2022, BMC cancer.

[5]  Chiahung Chou,et al.  Disparities in Cervical Cancer Screening with HPV Test among Females with Diabetes in the Deep South , 2021, Cancers.

[6]  P. Austin,et al.  Periodic screening for breast and cervical cancer in women with diabetes: a population-based cohort study , 2021, Cancer Causes & Control.

[7]  M. Vanstone,et al.  Understanding Black Women's Perspectives and Experiences of Cervical Cancer Screening: A Systematic Review and Qualitative Meta-synthesis , 2021, Journal of health care for the poor and underserved.

[8]  Tonatiuh V Mendoza,et al.  The OneFlorida Data Trust: a centralized, translational research data infrastructure of statewide scope , 2021, J. Am. Medical Informatics Assoc..

[9]  J. Trogdon,et al.  Reducing Poverty-Related Disparities in Cervical Cancer: The Role of HPV Vaccination , 2021, Cancer Epidemiology, Biomarkers & Prevention.

[10]  M. Gunter,et al.  Type 2 Diabetes and Cancer: An Umbrella Review of Observational and Mendelian Randomization Studies , 2021, Cancer Epidemiology, Biomarkers & Prevention.

[11]  Kanan T. Desai,et al.  A proposed new generation of evidence-based microsimulation models to inform global control of cervical cancer. , 2021, Preventive medicine.

[12]  A. Odoi,et al.  Investigation of geographic disparities of pre-diabetes and diabetes in Florida , 2020, BMC Public Health.

[13]  C. Flowers,et al.  Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society , 2020, CA: a cancer journal for clinicians.

[14]  S. Larsson,et al.  Is Type 2 Diabetes Causally Associated With Cancer Risk? Evidence From a Two-Sample Mendelian Randomization Study , 2020, Diabetes.

[15]  S. Saydah,et al.  Prevalence of Diabetes by Race and Ethnicity in the United States, 2011-2016. , 2019, JAMA.

[16]  M. White,et al.  Rural–Urban and Racial/Ethnic Disparities in Invasive Cervical Cancer Incidence in the United States, 2010–2014 , 2019, Preventing chronic disease.

[17]  S. Sulaiman,et al.  Multivariate Analysis on the Effects of Diabetes and related Clinical Parameters on Cervical Cancer Survival Probability , 2019, Scientific Reports.

[18]  S. Sulaiman,et al.  Multivariate Analysis on the Effects of Diabetes and related Clinical Parameters on Cervical Cancer Survival Probability , 2019, Scientific Reports.

[19]  Kelly L. Reburn,et al.  Cervical Cancer Screening Behaviors and Perceptions of Medical Mistrust among Rural Black and White Women , 2018, Journal of health care for the poor and underserved.

[20]  W. Hogan,et al.  Characterization of adult obesity in Florida using the OneFlorida clinical research consortium , 2018, Obesity science & practice.

[21]  A. Lenzi,et al.  Linking type 2 diabetes and gynecological cancer: an introductory overview , 2018, Clinical chemistry and laboratory medicine.

[22]  Xianquan Zhang,et al.  The association between diabetes/hyperglycemia and the prognosis of cervical cancer patients , 2017, Medicine.

[23]  J. King,et al.  Understanding Barriers to Cervical Cancer Screening in Women With Access to Care, Behavioral Risk Factor Surveillance System, 2014 , 2016, Preventing chronic disease.

[24]  P. Sasieni,et al.  Impact of cervical screening on cervical cancer mortality: estimation using stage-specific results from a nested case–control study , 2016, British Journal of Cancer.

[25]  D. W. Perkins,et al.  Racial and Economic Disparities in Diabetes in a Large Primary Care Patient Population. , 2016, Ethnicity & disease.

[26]  F. Guo,et al.  Effects of Cardiovascular Disease on Compliance with Cervical and Breast Cancer Screening Recommendations Among Adult Women. , 2015, Journal of women's health.

[27]  Jae-Wook Jeong,et al.  The Association between Type 2 Diabetes Mellitus and Women Cancer: The Epidemiological Evidences and Putative Mechanisms , 2015, BioMed research international.

[28]  Roland J Thorpe,et al.  Disparities in diabetes: the nexus of race, poverty, and place. , 2014, American journal of public health.

[29]  D. Lieberman,et al.  The Association of Type and Number of Chronic Diseases with Breast, Cervical, and Colorectal Cancer Screening , 2014, The Journal of the American Board of Family Medicine.

[30]  T. Mangione,et al.  Barriers to cervical cancer screening and follow-up care among Black Women in Massachusetts. , 2014, Journal of obstetric, gynecologic, and neonatal nursing : JOGNN.

[31]  S. Stokley,et al.  Delay and Refusal of Human Papillomavirus Vaccine for Girls, National Immunization Survey–Teen, 2010 , 2014, Clinical pediatrics.

[32]  地理学 United States Census Bureau , 2011 .

[33]  K. Richardson,et al.  Time-varying incidence of cancer after the onset of type 2 diabetes: evidence of potential detection bias , 2011, Diabetologia.

[34]  J. Webber Center , 2011 .

[35]  D. Harlan,et al.  Diabetes and Cancer , 2010, Diabetes Care.

[36]  Laura Sciacca,et al.  Diabetes and cancer. , 2009, Endocrine-related cancer.

[37]  Louette R. Johnson Lutjens Research , 2006 .

[38]  J. Schulman,et al.  On-schedule mammography rescreening in the National Breast and Cervical Cancer Early Detection Program. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[39]  Paul R. Rosenbaum,et al.  Optimal Matching for Observational Studies , 1989 .

[40]  Michigan.,et al.  Toxicological profile for dichloropropenes , 2008 .